Delivery Order SPE2DB22D2007-SPE2DB25FH9LJ

Award Date 2/28/25
Potential Completion Date 3/21/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Albumin (Human) 25% IV Solution 50ML. The $1,507.80 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,260.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 5% IV Solution in 250 mL packages, with a period of performance through December 13, 2024. The contract is a Firm Fixed Price Delivery Order and was not designated as a set-aside. In addition to this specific award, AmerisourceBergen holds a...
This federal contract award, valued at $1,005.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution 50mL, a critical medical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,206.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 25% IV Solution 50ML, a critical medical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.20 firm-fixed-price delivery order is for the supply of Albumin (Human) 25% IV Solution, a pharmaceutical product used in medical care. The contract has an ultimate completion date of November 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Albumin (Human) 25% IV Solution 50ML. The $1,206.24 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,883.70, is for the delivery of ALBUMIN (HUMAN) 5% IV SOLUTION 250ML, a medical supply. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 8, 2025. This award is not designated with a set-aside....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Albumin (Human) 25% IV Solution 50ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,206.24, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,496.24 firm fixed-price delivery order is for the supply of 100ml vials of 25% intravenous albumin (human) solution. The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Albumin (Human) 25% IV Solution 100ML to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,412.96, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of December 6, 2024 and was awarded on November 14, 2023. This contract award is not associated with a set-aside program....
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH9LJ
    Delivery Order

This federal contract award, valued at $2,296.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567421581 - ALBUMIN (HUMAN) 5% IV SOLUTION 250ML, a critical medical commodity.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.

This contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the required pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/30/25, 10:00 AM